[ORGANIZATION]
Retatrutid
Featured in 1 tracked story · first seen
Situations
Eli Lilly EloraTZP obesity drug clinical trials
3 clusters · 19 sources · last updated
Latest: Eli Lilly weight-loss drug combination shows significant results
Eli Lilly has reported results from Phase 2b clinical trials for EloraTZP, a combination therapy involving eloralinantide and tirzepatide designed to treat obesity and type 2 diabetes. Data presented at the European Ass